The Role of Umbilical Cord Thickness in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus

The Role of Umbilical Cord Thickness, Interventricular Septum Thickness and HbA1C Levels in Prediction of Fetal Macrosomia in Patients With Gestational Diabetes Mellitus

The aim of this work is the prediction of fetal macrosomia by measuring:

1. HbA1C.
2. Umbilical cord thickness.
3. Interventricular septum thickness.

Study Overview

• Status: Completed
• Conditions: Gestational Diabetes

Detailed Description

This prospective case control study will be carried out at Ain shams university maternity hospital between April 2015 and October 2015 on 80 patients. The patients will be divided into two groups, 40 pregnant women as case group with gestational diabetes mellitus and 40 non diabetic pregnant women as control group after being approved by the local hospital ethics and research committee. A verbal consent will be taken from each patient.

The following investigation will be performed:

1. Calculation of gestational age will be based on the last reliable menstrual period or ultrasound examination within the first trimester.

   The ultrasound examination will be with Voluson E6 equipped with a 3.5 Hz trans-abdominal probe at fetal medicine unit of maternity hospital Ain Shams University.

2. Ultrasound examination will be performed twice at 27-28 weeks and 36-37 weeks of gestation prospectively.

   During ultrasound, fetal biometry (biparietal diameter, abdominal circumference, femur length) and estimated fetal weight will be calculated automatically according to hadlock's formula additionally, the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device.

   The cross sectional area of Wharton's jelly will be computed by subtracting the cross sectional area of the vessels from that of the umbilical cord and the interventricular septum thickness will be measured.

3. HbA1c levels will be measured for diabetes patients.

All the patients will be subjected to :

1. Full history taking including last menstrual period, medical history and past obstetric history.
2. Detailed general physical history examination and obstetrics examination.
3. Ultrasound examination in fetal medicine unit maternity hospital Ain shams university.
4. Venous blood samples will be taken from patients with gestational diabetes mellitus in clinical pathology department Ain Shams University, to measure the level of HbA1c using immunoassay technique. The patients will be followed up till delivery. The neonates will be weighed and fetal macrosomia will be diagnosed if fetal weight is 4 kg or more.

• Study Type: Observational
• Enrollment (Actual): 80

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 35 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Non-Probability Sample

Study Population

This prospective case control study will be carried out at Ain shams university maternity hospital between April 2015 and October 2015 on 80 patients. The patients will be divided into two groups, 40 pregnant women as case group with gestational diabetes mellitus and 40 non diabetic pregnant women as control group after being approved by the local hospital ethics and research committee. A verbal consent will be taken from each patient.

Description

Inclusion Criteria:

1. Singleton gestation.
2. Gestational age over 27 weeks.
3. Intact membranes.
4. Normal umbilical morphology (two arteries and one vein).
5. Diagnosis of gestational diabetes.

Exclusion Criteria:

1. The presence of fetal congenital anomalies.
2. Multifetal pregnancy.
3. Maternal chronic diseases (hypertension, renal disease, cardiac and pulmonary disease, etc.).
4. Patients with a diagnosis such as oligohydramnios , pre-eclampsia and intrauterine growth retardation.
5. Patients who used cigarettes or alcohol during pregnancy.

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort
pregnant women with gestational diabetes; case group
non diabetic pregnant women; control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The Number of Participants Who Were Diagnosed With Fetal Macrosomia (Birth Weight)	The neonates will be weighed and fetal macrosomia will be diagnosed if fetal weight is 4 kg or more.	at birth

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Umbilical Cordcross-sectional Area	the sonographic cross sectional area of umbilical cord, the umbilical arteries and umbilical vein will be measured in a free loop of the umbilical cord using the software of the ultrasound device.	36-37 weeks of gestation
Prediction of Fetal Macrosomia by Measuring HbA1C in Participants	Venous blood samples will be taken from participants in clinical pathology department Ain Shams University, to measure the level of HbA1c using immunoassay technique.	36-37 weeks of gestation
Interventricular Septum Thickness	The interventricular septum thickness will be measured by ultrasound examination	36-37 weeks of gestation

Collaborators and Investigators

• Sponsor: Ain Shams University

Study record dates

Study Major Dates

• Study Start: April 1, 2015
• Primary Completion (Actual): October 1, 2015
• Study Completion (Actual): November 1, 2015

Study Registration Dates

• First Submitted: December 26, 2015
• First Submitted That Met QC Criteria: December 29, 2015
• First Posted (Estimate): December 31, 2015

Study Record Updates

• Last Update Posted (Estimate): August 18, 2016
• Last Update Submitted That Met QC Criteria: July 11, 2016
• Last Verified: July 1, 2016

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Diabetes Complications; Body Weight; Fetal Diseases; Pregnancy Complications; Pregnancy in Diabetics; Birth Weight; Diabetes Mellitus; Diabetes, Gestational; Fetal Macrosomia
• Other Study ID Numbers: Diabetes mellitus